drugset / Trial / NCT05951192
A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease
NaSingle-groupOpen-labelTreatment
Summary
Investigator-initiated, interventional, prospective study to assess the clinical and operational effectiveness of daprodustat in adult patients receiving in center hemodialysis or peritoneal home dialysis who are transitioning from Mircera to daprodustat.
Timeline
- Start
- 2023-07-01
- Primary completion
- 2024-02-14
- Completion
- 2024-02-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Daprodustat | Small molecule | 1 mg | Oral |
| Subject | Daprodustat | Small molecule | 2 mg | Oral |
| Subject | Daprodustat | Small molecule | 4 mg | Oral |
| Subject | Daprodustat | Small molecule | 6 mg | Oral |
| Subject | Daprodustat | Small molecule | 8 mg | Oral |